You are searching for: hsa04014

---

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T19160 Target Info	Target Name	Group IIA phospholipase A2 (GIIA sPLA2)
	Target type	Clinical trial Target
	Disease	Breast cancer;
	Drugs	KH064	Drug Info

T78429 Target Info	Target Name	Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
	Target type	Clinical trial Target
	Disease	Acute lymphoblastic leukaemia; Alzheimer disease;
	Drugs	Arsenic trioxide	Drug Info

T71266 Target Info	Target Name	RAC-gamma serine/threonine-protein kinase (AKT3)
	Target type	Successful Target
	Disease	Breast cancer; Triple negative breast cancer;
	Drugs	Capivasertib	Drug Info

T40097 Target Info	Target Name	Stress-activated protein kinase JNK1 (JNK1)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer; T-cell leukaemia;
	Drugs	NKP-1339	Drug Info

T07303 Target Info	Target Name	Vascular endothelial growth factor receptor 3 (FLT-4)
	Target type	Successful Target
	Disease	Renal cell carcinoma; Vascular restinosis;
	Drugs	Tivozanib	Drug Info

T44141 Target Info	Target Name	Angiopoietin-1 (ANGPT1)
	Target type	Clinical trial Target
	Disease	Breast cancer; Neuropathic pain;
	Drugs	Trebananib	Drug Info

T21960 Target Info	Target Name	Angiopoietin-2 (ANGPT2)
	Target type	Successful Target
	Disease	Neovascular age-related macular degeneration; Breast cancer;
	Drugs	Faricimab	Drug Info

T56510 Target Info	Target Name	Apoptosis regulator Bcl-xL (BCL-xL)
	Target type	Clinical trial Target
	Disease	Myelofibrosis; Relapsed or refractory chronic lymphocytic leukaemia;
	Drugs	ABT-263	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.